Faeq Husain-Syed, István Vadász, Jochen Wilhelm, Hans-Dieter Walmrath, Werner Seeger, Horst-Walter Birk, Birgit Jennert, Hartmut Dietrich, Susanne Herold, Janina Trauth, Khodr Tello, Michael Sander, Rory E Morty, Heiko Slanina, Christian G Schüttler, John Ziebuhr, Shadi Kassoumeh, Claudio Ronco, Fiorenza Ferrari, Klaus Warnatz, Klaus Stahl, Benjamin Seeliger, Marius M Hoeper, Tobias Welte, Sascha David
Despite the pandemic status of COVID-19, there is limited information about host risk factors and treatment beyond supportive care. Immunoglobulin G (IgG) could be a potential treatment target. Our aim was to determine the incidence of IgG deficiency and associated risk factors in a cohort of 62 critically ill patients with COVID-19 admitted to two German ICUs (72.6% male, median age: 61 yr). Thirteen (21.0%) of the patients displayed IgG deficiency (IgG < 7 g/L) at baseline (predominant for the IgG1, IgG2, and IgG4 subclasses)...
April 1, 2021: American Journal of Physiology. Lung Cellular and Molecular Physiology